{
  "name": "Headaches",
  "slug": "headaches",
  "icon": "ü§ï",
  "color": "bg-orange-100 text-orange-800 border-orange-200",
  "toc": [
    {
      "level": 3,
      "text": "Treatments",
      "id": "treatments"
    },
    {
      "level": 3,
      "text": "Treatments",
      "id": "treatments-2"
    },
    {
      "level": 1,
      "text": "Headache Classification",
      "id": "headache-classification"
    },
    {
      "level": 2,
      "text": "Tension-Type",
      "id": "tension-type"
    },
    {
      "level": 2,
      "text": "Abdominal Migraine",
      "id": "abdominal-migraine"
    },
    {
      "level": 2,
      "text": "Chronic Headaches",
      "id": "chronic-headaches"
    },
    {
      "level": 2,
      "text": "Hemiplegic Migraine",
      "id": "hemiplegic-migraine"
    },
    {
      "level": 2,
      "text": "New Daily Persistent Headache",
      "id": "new-daily-persistent-headache"
    },
    {
      "level": 2,
      "text": "Hemicrania Continua",
      "id": "hemicrania-continua"
    },
    {
      "level": 2,
      "text": "Idipathic Intracranial Hypertension (pseudotumor cerebri)",
      "id": "idipathic-intracranial-hypertension-pseudotumor-cerebri"
    },
    {
      "level": 1,
      "text": "Headache Red Flags (Consider Imaging)",
      "id": "headache-red-flags-consider-imaging"
    },
    {
      "level": 1,
      "text": "Inpatient Migraine Management",
      "id": "inpatient-migraine-management"
    },
    {
      "level": 2,
      "text": "Inclusion & Exclusion",
      "id": "migraine-inclusion-exclusion"
    },
    {
      "level": 2,
      "text": "Baseline Checks",
      "id": "migraine-baseline-checks"
    },
    {
      "level": 2,
      "text": "ED Environment & Fluids",
      "id": "migraine-ed-environment"
    },
    {
      "level": 2,
      "text": "Stepwise Acute Treatment (ED)",
      "id": "migraine-stepwise-treatment"
    },
    {
      "level": 3,
      "text": "Step 1 ‚Äî First Cocktail",
      "id": "migraine-step-1"
    },
    {
      "level": 3,
      "text": "Step 2 ‚Äî Add VPA If Needed",
      "id": "migraine-step-2"
    },
    {
      "level": 3,
      "text": "Step 3 ‚Äî Persistent Pain",
      "id": "migraine-step-3"
    },
    {
      "level": 2,
      "text": "Inpatient (Neurology)",
      "id": "migraine-inpatient"
    },
    {
      "level": 3,
      "text": "Step 4 ‚Äî General Inpatient",
      "id": "migraine-step-4"
    },
    {
      "level": 3,
      "text": "Step 5 ‚Äî Magnesium / VPA",
      "id": "migraine-step-5"
    },
    {
      "level": 3,
      "text": "Step 6 ‚Äî DHE Protocol",
      "id": "migraine-step-6"
    },
    {
      "level": 2,
      "text": "Discharge",
      "id": "migraine-discharge"
    },
    {
      "level": 1,
      "text": "Emergency Headache Treatment",
      "id": "emergency-headache-treatment"
    }
  ],
  "html": "<h3 id=\"treatments\">Treatments</h3><h3 id=\"treatments-2\">Treatments&nbsp;</h3><p><strong>Headache acute meds</strong>&nbsp;</p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Medication</strong>&nbsp;</p></td><td><p><strong>Form</strong>&nbsp;</p></td><td><p><strong>Dosage</strong>&nbsp;</p></td><td><p><strong>Max</strong>&nbsp;</p></td><td><p><strong>Freq</strong>&nbsp;</p></td><td><p><strong>SE</strong>&nbsp;</p></td></tr><tr><td><p>Ibuprofen&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>10 mg/kg/dose&nbsp;</p></td><td><p>800 mg&nbsp;</p></td><td><p>Q 6-8 h&nbsp;</p></td><td><p>GI bleed&nbsp;</p></td></tr><tr><td><p>Ketorolac&nbsp;</p><p>(Toradol)&nbsp;</p></td><td><p>PO&nbsp;</p><p>IV/IM&nbsp;</p></td><td><p>Greater‚ÄØthan‚ÄØ50 kg: 10-30 mg&nbsp;</p><p>Less‚ÄØthan‚ÄØ50 kg: 0.5 mg/kg/dose&nbsp;</p></td><td><p>30 mg&nbsp;</p><p>15 mg&nbsp;</p></td><td><p>Q 6-8 h&nbsp;</p><p>Q 6-8 h&nbsp;</p></td><td><p>GI bleed, decr plt fxn&nbsp;</p></td></tr><tr><td><p>Naproxen&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>10 mg/kg/dose&nbsp;</p></td><td><p>500 mg&nbsp;</p></td><td><p>Q 12 h&nbsp;</p></td><td><p>GI Bleed, drowsy, dec plts&nbsp;</p></td></tr><tr><td><p>Acetaminophen&nbsp;</p></td><td><p>PO/PR&nbsp;</p></td><td><p>15 mg/kg/dose&nbsp;</p></td><td><p>450-650 mg&nbsp;</p></td><td><p>Q 4-6 h&nbsp;</p></td><td><p>Hepatic toxicity&nbsp;</p></td></tr><tr><td><p>Metoclopramide&nbsp;</p><p>(Reglan)&nbsp;</p></td><td><p>PO/IV/IM&nbsp;</p></td><td><p>0.1- 0.15 mg/kg/dose&nbsp;</p></td><td><p>10 mg&nbsp;</p></td><td><p>Q 6 h&nbsp;</p></td><td><p>anxiety, diarrhea leucopenia, dystonic reaction&nbsp;</p></td></tr><tr><td><p>Promethazine&nbsp;</p><p>(Phenergan)&nbsp;</p></td><td><p>PO/IM/ IV/PR&nbsp;</p></td><td><p>0.25-1 mg/kg/dose&nbsp;</p></td><td><p>25 mg&nbsp;</p></td><td><p>Q 4-6 h&nbsp;</p></td><td><p>blurred vision, dystonic rxn&nbsp;</p></td></tr><tr><td><p>Prochlorperazine&nbsp;</p><p>(Compazine)&nbsp;</p></td><td><p>PO/PR&nbsp;</p><p>IM&nbsp;</p><p>IV&nbsp;</p></td><td><p>0.1 mg/kg/dose&nbsp;</p><p>0.1 mg/kg/<strong>DAY</strong>&nbsp;</p><p>0.15 mg/kg/dose&nbsp;</p></td><td><p>10 mg&nbsp;</p><p>10 mg&nbsp;</p></td><td><p>Q 6-8 h&nbsp;</p></td><td></td></tr><tr><td><p>Diphenhydramine&nbsp;</p><p>(Benadryl)&nbsp;</p></td><td><p>PO/IV/IM&nbsp;</p></td><td><p>0.5 mg/kg/dose&nbsp;</p></td><td><p>50 mg&nbsp;</p></td><td><p>Q 6 h&nbsp;</p></td><td><p>Nausea, blurred vision, xerostoma&nbsp;</p></td></tr><tr><td><p>Rizatriptan* (Maxalt)&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>5-10 mg/dose&nbsp;</p></td><td><p>10 mg&nbsp;</p></td><td><p>Can repeat q1 h x2&nbsp;</p><p>Max dose: 30 mg/24 hours&nbsp;</p></td><td><p>Dizziness, chest pain and tightness, bad taste, paresthesias&nbsp;</p></td></tr><tr><td><p>Sumatriptan+&nbsp;</p><p>(Imitrex)&nbsp;</p></td><td><p>PO *&nbsp;</p><p>IN&nbsp;</p><p>SC&nbsp;</p></td><td><p>25-100 mg&nbsp;</p><p>5 mg&nbsp;</p><p>20 mg&nbsp;</p><p>3, 4,‚ÄØor‚ÄØ6 mg&nbsp;</p></td><td><p>200 mg/day‚ÄØPO&nbsp;</p></td><td><p>Can repeat in 2 h&nbsp;</p></td><td></td></tr><tr><td><p>Naratriptan&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>1-2.5 mg/dose&nbsp;</p></td><td><p>5 mg/day&nbsp;</p></td><td><p>Can repeat in 4 h&nbsp;</p></td><td></td></tr><tr><td><p>Zolmitriptan+&nbsp;</p><p>(Zolmig)&nbsp;</p></td><td><p>PO&nbsp;</p><p>IN&nbsp;</p></td><td><p>2.5-5 mg/dose&nbsp;</p><p>2.5 or 5 mg/dose&nbsp;</p></td><td><p>10 mg/day&nbsp;</p></td><td><p>Can‚ÄØrepeat‚ÄØin 2 h&nbsp;</p></td><td></td></tr><tr><td><p>Eletriptan&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>20 or 40 mg/dose&nbsp;</p></td><td><p>80 mg/day&nbsp;</p></td><td><p>Can repeat in 2 h&nbsp;</p></td><td></td></tr><tr><td><p>Almotriptan*&nbsp;</p></td><td><p>PO&nbsp;</p></td><td><p>6.25-12.5 mg&nbsp;</p></td><td><p>25 mg&nbsp;</p></td><td><p>Can repeat in 2 h&nbsp;</p></td><td></td></tr><tr><td><p>Dihydroergotamine&nbsp;</p><p>(DHE)&nbsp;</p></td><td><p>IV&nbsp;</p><p>IN&nbsp;</p></td><td><p>0.2-1 mg&nbsp;</p><p>0.5 mg eachnarerepeat in 15 min, can repeat in 1 h&nbsp;</p></td><td><p>1 mg&nbsp;</p></td><td><p>Q 8 h&nbsp;</p></td><td><p>Vasoconstriction, flushing, Nausea, muscle cramps&nbsp;</p></td></tr><tr><td><p>Caffeine (base)&nbsp;</p></td><td><p>IV&nbsp;</p></td><td><p>Up to 5-10 mg/kg&nbsp;</p></td><td></td><td><p>Over 30 minutes&nbsp;</p></td><td><p>Hyperactive, Inc HR, agitation,&nbsp;</p></td></tr><tr><td><p>Valproate sodium&nbsp;</p></td><td><p>IV&nbsp;</p></td><td><p>10- 20 mg/kg/dose&nbsp;</p></td><td><p>1000 mg&nbsp;</p></td><td><p>Once&nbsp;</p></td><td><p>Sedation, tremor&nbsp;</p></td></tr><tr><td><p>Magnesium&nbsp;</p></td><td><p>IV&nbsp;</p></td><td><p>30 mg/kg/dose&nbsp;</p></td><td><p>2000 mg&nbsp;</p></td><td><p>Once&nbsp;</p></td><td><p>Hypotension&nbsp;</p></td></tr></tbody></table></div><p>* FDA approved in children greater than 6 years (Rizatriptan) and adolescents (Rizatriptan, Almotriptan, Zominasal, and Treximetal); + Safety and efficacy data present in pediatric populations.&nbsp;</p><p><strong>Prophylactic Meds</strong>&nbsp;</p><div class=\"table-wrap\"><table><tbody><tr><td><p><strong>Medications</strong>&nbsp;</p></td><td></td><td><p><strong>Peds/adolescents</strong>&nbsp;</p></td><td><p><strong>Adult</strong>&nbsp;</p></td><td><p><strong>Formulations</strong>&nbsp;</p></td><td><p><strong>Side-effects</strong>&nbsp;</p></td></tr><tr><td><p>Amitriptyline&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Maintain&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>10 mg nightly&nbsp;</p><p>10 mg weekly&nbsp;</p><p>1 mg/kg/DAY&nbsp;</p></td><td><p>10-25 mg&nbsp;</p><p>25 mg&nbsp;</p><p>150 mg&nbsp;</p><p>300 mg&nbsp;</p></td><td><p>Tab: 10, 25, 50, 75, 100, 150 mg&nbsp;</p></td><td><p>Constipation, dry mouth, arrhythmia, sedation&nbsp;</p></td></tr><tr><td><p>Nortriptyline&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Maintain&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>10 mg nightly&nbsp;</p><p>10 mg weekly&nbsp;</p><p>1 mg/kg/DAY&nbsp;</p></td><td><p>10-25 mg&nbsp;</p><p>25 mg&nbsp;</p><p>75 mg&nbsp;</p><p>150 mg&nbsp;</p></td><td><p>Cap: 10, 25, 50, 75 mg&nbsp;</p><p>Sol: 10 mg/5mL&nbsp;</p></td><td><p>Constipation, dry mouth, arrhythmia, sedation&nbsp;</p></td></tr><tr><td><p>Topiramate&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Maintain&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>25 mg nightly&nbsp;</p><p>25 mg q 2 weeks&nbsp;</p></td><td><p>25 mg qhs&nbsp;</p><p>25 mg weekly&nbsp;</p><p>100 mg/DAY&nbsp;</p><p>200 mg/DAY&nbsp;</p></td><td><p>Sprinkles: 15, 25 mg&nbsp;</p><p>Tab: 25, 50, 100, 200 mg&nbsp;</p></td><td><p>Weight loss, kidney stones, paresthesias, glaucoma.&nbsp;</p></td></tr><tr><td><p>Valproic acid&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>15 mg/kg/DAY div BID&nbsp;</p><p>5-10 mg/kg/DAY weekly&nbsp;</p><p>1000 mg/DAY&nbsp;</p></td><td><p>250 mg BID&nbsp;</p><p>250 mg weekly&nbsp;</p><p>250-500 mg BID&nbsp;</p><p>1000 mg/DAY&nbsp;</p></td><td><p>Cap: 250 mg&nbsp;</p><p>DR or XR tab: 125, 250 mg&nbsp;</p><p>Sol: 250/5 mL&nbsp;</p></td><td><p>Wt gain, bruising, hair loss, hepatotoxicity&nbsp;</p></td></tr><tr><td><p>Propranolol&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>10 mg TID&nbsp;</p><p>10 mg‚ÄØweekly&nbsp;</p><p>40 mg TID&nbsp;</p></td><td><p>20 mg TID&nbsp;</p><p>20 mg q3wks&nbsp;</p><p>40 mg TID&nbsp;</p><p>80 mg TID&nbsp;</p></td><td><p>Cap ER: 60, 80, 120, 160 mg&nbsp;</p><p>Sol: 4 mg/mL or 8 mg/mL&nbsp;</p><p>Tab: 10-80 mg&nbsp;</p></td><td><p>Hypotension, vivid dreams<strong>depression</strong>&nbsp;</p></td></tr><tr><td><p>Metoprolol&nbsp;</p></td><td><p>Start Dose&nbsp;</p></td><td><p>2-6 mg/kg/DAY&nbsp;</p></td><td></td><td></td><td><p>same&nbsp;</p></td></tr><tr><td><p>Verapamil&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Maintain&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>2 mg/kg/DAY&nbsp;</p><p>4-8 mg/kg/DAY div TID&nbsp;</p><p>480 mg/DAY&nbsp;</p></td><td><p>80 mg BID&nbsp;</p><p>40 mg weekly&nbsp;</p><p>640 mg/DAY&nbsp;</p></td><td><p>SR: 120, 180, 240 mg&nbsp;</p><p>ER: 120, 180, 240 mg&nbsp;</p><p>Tab: 40, 80, 120 mg&nbsp;</p></td><td><p>Hypotension, nausea, AV block, wt gain&nbsp;</p></td></tr><tr><td><p>Cyproheptadine&nbsp;</p><p>(Periactin)&nbsp;</p></td><td><p>Start Dose&nbsp;</p><p>Inc By&nbsp;</p><p>Maintain&nbsp;</p><p>Max dose&nbsp;</p></td><td><p>2 mg nightly&nbsp;</p><p>2 mg weekly&nbsp;</p><p>4 mg nightly&nbsp;</p><p>12 mg nightly&nbsp;</p></td><td><p>4 mg&nbsp;</p><p>4 mg q3 weeks&nbsp;</p><p>8 mg&nbsp;</p><p>8 mg&nbsp;</p></td><td><p>Sol: 2 mg/5 mL&nbsp;</p><p>Tab: 4 mg&nbsp;</p></td><td><p>Sedation, wt gain&nbsp;</p></td></tr><tr><td><p>Magnesium&nbsp;</p></td><td><p>&lt;9 yo&nbsp;</p><p>&gt;9 yo&nbsp;</p></td><td><p>100 mg daily&nbsp;</p><p>400 mg daily&nbsp;</p></td><td><p>200 mg daily&nbsp;</p></td><td></td><td><p>Loose stools&nbsp;</p></td></tr><tr><td><p>Co enzyme q10&nbsp;</p></td><td></td><td><p>1-3 mg/kg/DAY&nbsp;</p></td><td><p>200 mg daily&nbsp;</p></td><td></td><td></td></tr><tr><td><p>Riboflavin (B2)&nbsp;</p></td><td></td><td><p>100 mg/DAY&nbsp;</p></td><td><p>100 mg daily&nbsp;</p></td><td></td><td><p>Deep yellow colored urine&nbsp;</p></td></tr></tbody></table></div><h1 id=\"headache-classification\">Headache Classification</h1><h2 id=\"migraine-without-aura\">Migraine without aura</h2><p>Classification:</p><p>A. At least 5 attacks fulfilling B-D, not attributable to another cause </p><p>B. Headache lasting 2-72 hours (4hrs in adults) </p><p>C. Headache has &gt; 2 of the following </p><p>a. Unilateral or bilateral (must be unilateral in adults) </p><p>b. Pulsating quality </p><p>c. Moderate- Severe </p><p>d. Aggravated by movement </p><p>D. Headache has &gt;1 of the following </p><p>a. Nausea or vomiting </p><p>b. Photo AND phonophobia </p><h2 id=\"tension-type\">Tension-Type</h2><p>At least ten attacks fulfilling criteria A-C </p><p>A. Headache attacks lasting 30 minutes to 72 hours (untreated or unsuccessfully treated) </p><p>B. Headache attack has at least two of the following characteristics: </p><p>a. Bilateral location</p><p>b. Band/pressure quality</p><p>c. mild to moderate pain</p><p>d. not aggravated by routine physical activity </p><p>C. During headache: </p><p>a. no nausea or vomiting</p><p>b. photophobia OR phonophobia </p><p>D. Not attributed to another disorder </p><h2 id=\"migraine-with-brainstem-aura-basilar-type-migraine\">Migraine with brainstem aura (Basilar type migraine)</h2><p>Classification:</p><p>A. At least 2 attacks fulfilling criteria B-D</p><p>B. Aura consisting of visual, sensory, and or speech language symptoms, each fully reversible, but no motor or retinal symptoms</p><p>C. at least two of the brainstem symptoms:</p><p>1. Dysarthria, 2. Vertigo, 3. Tinnitus, 4. Hypacusia, 5. Diplopia, 6. Ataxia 7. decreased level of consciousness</p><p>D. At least two of the following:</p><p>1. at least one aura symptom develops gradually over ‚â•5 minutes and/or different aura symptoms occur in succession over ‚â•5 minutes.</p><p>2. each aura symptom lasts 5-60 minutes, motor symptoms last less than 72 hours. </p><p>3. at least one aura symptom is unilateral.</p><p>4. the aura is accompanied or followed within 60 minutes by a headache.</p><h2 id=\"abdominal-migraine\">Abdominal Migraine</h2><p><strong>Abdominal pain not accompanied by migraine headache</strong></p><p>Diagnostic criteria include at least five attacks fulfilling criteria A-C: </p><p>Pain has at least two of the following three characteristics: </p><ul><li> Midline location, periumbilical, or poorly localized </li><li>Dull or ‚Äújust sore‚Äù quality </li><li> Moderate or severe intensity </li></ul><p> During attacks, at least two of the following: </p><ul><li>Anorexia </li><li>Nausea</li><li>Vomiting</li><li>Pallor</li></ul><p>Attacks last 2 to 72 hours when untreated or unsuccessfully treated </p><p>Complete freedom from symptoms between attacks </p><p>Not attributed to another disorder </p><p>GI workup negative</p><h2 id=\"chronic-headaches\">Chronic Headaches</h2><p>Both migraines and tension-type headaches can become chronic, meaning that they occur at least 15 days per month for greater than 3 months </p><p>Chronic headaches can result from taking some types of medication‚Äîfor example, acetaminophen (Tylenol), ibuprofen (Motrin), caffeine, and some prescription medications‚Äîalmost every day. These are called <strong>medication overuse headaches</strong>. The most effective way to make these headaches better is to stop taking pain medicines altogether for 2 to 3 weeks. After that time, use of pain-relievers is limited to no more that 2 to 3 times per week.</p><h2 id=\"hemiplegic-migraine\">Hemiplegic Migraine</h2><p>Classification</p><p>A. At least 2 attacks fulfilling criteria B and C</p><p>B. Aura consisting of both of the following</p><p>1. fully reversible motor weakness</p><p>2. fully reversible visual, sensory and or speech/language symptoms</p><p>C. At least two of the following:</p><p>1. at least one aura symptom develops gradually over ‚â•5 minutes and/or different aura symptoms occur in succession over ‚â•5 minutes</p><p>2. each aura symptom lasts 5-60 minutes, motor symptoms last less than 72 hours. </p><p>3. at least one aura symptom is unilateral</p><p>4. The aura is accompanied or followed within 60 minutes by a headache</p><p>Familial Hemiplegic Migraine if at least one first- or second-degree relative has had attacks fulfilling these criteria.  Sporadic Hemiplegic Migraine if no family history.  No need for genetic testing</p><p><strong>ED Management</strong></p><p>If currently weak</p><p>If weakness is resolved and there is a suspicion for hemiplegic migraine</p><ul><li>AND this is first episode of Hemiplegic Migraine: needs urgent but not emergent MRI stroke protocol (within 24 hours)</li><li>AND this is a recurrent episode and has had MRI stroke protocol prior‚Äîthen just treat migraine. If this is within 30-60 days of previous new episodes, then consider HANDL disease and get LP. </li></ul><h2 id=\"new-daily-persistent-headache\">New Daily Persistent Headache</h2><p>Classification:</p><p>A. Headache that, within 3 months of onset, fulfils criteria B-D</p><p>B. Headache is present daily, and is unremitting, for &gt;3 months</p><p>C. At least two of the following pain characteristics:</p><p>1. bilateral location</p><p>2. pressing/tightening (non-pulsating) quality</p><p>3. mild or moderate intensity</p><p>4. not aggravated by routine physical activity such as walking or climbing</p><p>D. Both of the following:</p><p>1. no more than one of photophobia, phonophobia or mild nausea</p><p>2. neither moderate or severe nausea nor vomiting</p><p>Diagnostic work up (focus on ruling out secondary causes)</p><p>MRI/MRV with and without contrast to rule out the following:</p><ul><li>Pachymeningeal enhancement for viral etiologies and low pressure headache</li><li>CSVT </li></ul><p>LP </p><ul><li>Opening pressure for elevated intracranial pressure.</li><li>Cell count and glucose and protein to evaluate for indolent infections, inflammatory disease, etc.</li></ul><p>Therapies</p><p>IV Solumedrol infusions 30 mg/kg/dose max of 1 gram daily for 3 days</p><p>Consider Lyrica. Patient usually has to fail Neurontin first for insurance coverage. If patient has Fibromyalgia, do not forget to use both as diagnosis when ordering Lyrica as it is FDA approved this indication. </p><p>Nerve blocks q 2 weeks x 3</p><p>Botox</p><h2 id=\"hemicrania-continua\">Hemicrania Continua</h2><p>Classification:</p><p>A. Headache for &gt;3 months fulfilling criteria B-D</p><p>B. All of the following characteristics:</p><p>1. unilateral pain without side-shift</p><p>2. daily and continuous, without pain-free periods</p><p>3. moderate intensity, but with exacerbations of severe pain</p><p>C. At least one of the following autonomic features occurs during</p><p>exacerbations and ipsilateral to the side of pain:</p><p>1. conjunctival injection and/or lacrimation</p><p>2. nasal congestion and/or rhinorrhoea</p><p>3. ptosis and/or miosis</p><p>D. Complete response to therapeutic doses of indomethacin</p><p><strong>Indomethacin Protocol</strong></p><p>Typical adolescent dosing. If less than ~ 40 kg, use weight based dosing. (don‚Äôt forget the Ranitidine)</p><p>25 mg po TID for 3 days (0.3-0.6 mg/kg/dose)</p><p>50 mg po TID for 3 days (0.6-1 mg/kg/dose)</p><p>75 mg po TID for 3 days (1-1.3 mg/kg/dose) (max 225 mg a day)</p><p>If no effect, then titrate off as follows.</p><p>50 mg po TID for 3 days</p><p>25 mg po TID for 3 days then STOP</p><p>If there is effect, titrate to lowest effective dosing.</p><h2 id=\"idipathic-intracranial-hypertension-pseudotumor-cerebri\">Idipathic Intracranial Hypertension (pseudotumor cerebri)</h2><p>Diagnosis via modified Dandy Criteria: </p><ul><li>Signs and symptoms of increased intracranial pressure (some or all may be present)<ol><li>Headache worse with laying flat or coughing, straining ‚Äì can be progressive</li><li>Transient visual obscurations</li><li>Pulsatile tinnitus</li></ol></li><li>Normal neurologic exam with the exception of the following (which may or may not be present):<ol><li>Papilledema</li><li>Enlarged blind spot</li><li>CN VI palsy</li></ol></li><li>CSF opening pressure &gt;28 cm H2O without cytologic abnormalities (low CSF protein okay) ‚Äì OP will be higher in peds (~28cm H2O)</li><li>MRI of the brain without any intracranial pathology (including lack of cerebral sinus venous thrombosis) ‚Äì <strong>recommended imaging ‚Äì MRI and MRV</strong></li></ul><p>Medical Conditions/Medications that have been reported to be associated with IIH:</p><ul><li>Obesity</li><li>Female gender</li><li>Rapid weight gain</li><li>Obstructive sleep apnea</li><li>Excess vitamin A (esp Accutane for acne in teens)</li><li>Tetracyclines (minocycline or doxycycline)</li><li>OCPs</li><li>Growth hormone (proposed that GH crosses BBB increasing local IGF1 which increases CSF production)</li><li>Hypothyroidism treated with levothyroxins (proposed that thyroxine regulates Na channels affecting fluid shifts intracranially)</li><li>Corticostroid withdrawal</li></ul><p>Can treat with <strong>acetazolamide first line</strong></p><ul><li>Acetazolamide (carbonic anhydrase inhibitor)<ol><li>25mg/kg/day BID-TID up to a max of 100 mg/kg or 2000 mg/day</li><li>Usually treat 3-9 months until headache and papilledema resolve</li><li>SEs: GI upset, paresthesias, electrolyte abnormalities (acidosis, hyper or hypoglycemia, hypokalemia, hyponatremia), confusion, convulsions</li></ol></li><li>Topiramate (mild carbonic anhydrase activity) ‚Äì not as effective an as Acetazolamide</li><li>In acute situations with severe visual loss, IV methypred short course can be given</li><li>Optic nerve fenestration (thought to have a general effect on lowering CSF pressure rather than just local)</li><li>CSF shunting ‚Äì uncommon, lumboperitoneal shunting, lots of potential complications as with other shunts</li></ul><h1 id=\"headache-red-flags-consider-imaging\">Headache Red Flags (Consider Imaging)</h1><div class=\"callout-box\"><p>Focal neurologic deficit </p><p>Young age (less than 8 years old) </p><p>Posteriorly-located headache ‚Äì if migraine symptoms increase and neuro exam normal, not a tumor</p><p>New onset or worsening headache that is not a migraine</p><p>Postural headache </p><p>Nighttime awakening headache and or vomiting </p><p>Early morning headache and or vomiting </p><p>Neurocutaneous stigmata </p></div><p>** Note - &gt;95% of children with intracranial mass will have objective neurologic findings</p><h1 id=\"inpatient-migraine-management\">Inpatient Migraine Management ‚Äî Status Migrainosus</h1>\n<p><em>Acute Status Migrainosus (pediatric). Not for chronic daily HA/chronic migraine ‚Äî individualize those; goal is not necessarily 0/10. Call Neuro for complex cases.</em></p>\n\n<h2 id=\"migraine-inclusion-exclusion\">Inclusion &amp; Exclusion</h2>\n<ul>\n<li><strong>Include:</strong> Migraine per ICHD-3 criteria</li>\n<li><strong>Exclude / call Neuro stat:</strong> New migraine with brainstem aura, hemiplegic migraine, or retinal migraine; secondary HA (IIH, other systemic cause)</li>\n</ul>\n\n<h2 id=\"migraine-baseline-checks\">Baseline Checks</h2>\n<ul>\n<li>Full medication history including recent HA meds; assess for medication overuse</li>\n<li>Screen for pregnancy, liver/renal disease, CV disease, uncontrolled HTN</li>\n<li><strong>Avoid triptans/DHE in:</strong> CV disease/CVA/PVD, brainstem/hemiplegic/retinal migraine, recent triptan/DHE per standard intervals</li>\n</ul>\n\n<h2 id=\"migraine-ed-environment\">ED Environment &amp; Fluids</h2>\n<ul>\n<li>Quiet dark room; no screens; normal sleep/meals; encourage ambulation</li>\n<li><strong>NS bolus</strong> 20 mL/kg IV (max 1 L) unless contraindicated</li>\n</ul>\n\n<h2 id=\"migraine-stepwise-treatment\">Stepwise Acute Treatment (ED)</h2>\n\n<h3 id=\"migraine-step-1\">Step 1 ‚Äî First Cocktail</h3>\n<ul>\n<li><strong>Diphenhydramine</strong> 1 mg/kg IV (max 25 mg) ‚Äî give 15‚Äì30 min <em>before</em> antidopaminergic</li>\n<li><strong>Prochlorperazine</strong> 0.15 mg/kg IV (max 10 mg) ‚Äî or <strong>Metoclopramide</strong> 0.15 mg/kg IV (max 10 mg) if unavailable</li>\n<li><strong>Ketorolac</strong> 0.5 mg/kg IV (max 30 mg) if no NSAID in past 6h</li>\n<li>Start ¬Ω maintenance IVF</li>\n<li>Reassess at 30‚Äì60 min</li>\n</ul>\n\n<h3 id=\"migraine-step-2\">Step 2 ‚Äî Add VPA If Needed</h3>\n<ul>\n<li>If HA resolved: consider discharge</li>\n<li>If persists and urine HCG negative (if indicated): <strong>Valproate</strong> 20 mg/kg IV over 5 min (max 1,000 mg)</li>\n<li>May repeat migraine cocktail up to 3 total doses in 24h</li>\n<li>Reassess 30‚Äì60 min later</li>\n</ul>\n\n<h3 id=\"migraine-step-3\">Step 3 ‚Äî Persistent Pain</h3>\n<ul>\n<li>If improved: discharge with <strong>VPA 10 mg/kg/day PO divided BID (max 500 mg/day)</strong> √ó 1‚Äì2 weeks + Neuro f/u 2‚Äì4 weeks</li>\n<li>If still refractory: <strong>admit; call Neuro</strong></li>\n</ul>\n\n<h2 id=\"migraine-inpatient\">Inpatient (Neurology)</h2>\n\n<h3 id=\"migraine-step-4\">Step 4 ‚Äî General Inpatient</h3>\n<ul>\n<li>Admit to Neuro; quiet/dark room, restricted screens, normal sleep/eating, ambulation</li>\n<li>Continue ¬Ω maintenance IVF</li>\n<li>May repeat migraine cocktail q6h (total ‚â§ 3 doses since ED)</li>\n</ul>\n\n<h3 id=\"migraine-step-5\">Step 5 ‚Äî Magnesium / VPA</h3>\n<ul>\n<li><strong>MgSO‚ÇÑ</strong> 30 mg/kg IV over 30 min (max 2 g) if Mg ‚â§ 2.3; check Mg and BP before/during/after; repeat once after 2h if still needed and level ‚â§ 2.3</li>\n<li>Consider repeat <strong>Valproate</strong> 20 mg/kg IV (max 1,000 mg)</li>\n</ul>\n\n<h3 id=\"migraine-step-6\">Step 6 ‚Äî DHE Protocol</h3>\n<p><strong>Contraindications ‚Äî avoid with:</strong> recent triptan (‚â§ 24h), MAOIs/ARVs/macrolides, CV disease, non-migraine HA. Pre-treat with antiemetic ¬± diphenhydramine.</p>\n<ul>\n<li>IV DHE: start low (<strong>0.1‚Äì0.25 mg</strong>), titrate q8h up to <strong>1 mg/dose</strong> per institutional max</li>\n<li>Monitor BP q15 min before and 15 min after each dose; watch for chest pain, N/V, cold/ischemic extremities, paresthesias</li>\n<li>Response often after ~5th dose; transient early worsening is <em>not</em> a reason to stop</li>\n<li>Aim for 1‚Äì2 doses beyond 0/10 if tolerated</li>\n</ul>\n<p><strong>Other options:</strong> Consider triptan if not yet used and no contraindications. Steroids: <strong>dexamethasone</strong> 0.25‚Äì0.5 mg/kg or <strong>methylprednisolone</strong> 1 mg/kg (counsel re AVN risk). Avoid opioids/barbiturates. Consider early Behavioral Health referral and acupuncture.</p>\n\n<h2 id=\"migraine-discharge\">Discharge</h2>\n<ul>\n<li>Goal for status migrainosus: near/at 0/10 pain</li>\n<li>Provide preventive and abortive home regimen</li>\n<li>If effective IV VPA: discharge with <strong>VPA 10 mg/kg/day PO BID (max 500 mg/day)</strong> √ó 2 weeks</li>\n<li>Clear return precautions and scheduled Neuro HA clinic follow-up</li>\n</ul>\n\n<h1 id=\"emergency-headache-treatment\">Emergency Headache Treatment</h1><p>A recent study of oral VPA tapers suggest there is likely no benefit in reducing migraine recurrence after treatment with IV VPA in the ED. </p><p>          Citation: Rosenthal S, Mazzio E, Gilbert H et al. Efficacy of Intravenous Valproic Acid and Oral Valproic Acid Tapers for Treatment of Pediatric Headaches in the Emergency Department. Accepted for publication: Neurol Clin Pract. 2023</p><p><em>See <strong>Inpatient Migraine Management ‚Äî Status Migrainosus</strong> above for the full stepwise protocol.</em></p>\n<p><strong>INTRANASAL KETAMINE FOR STATUS MIGRAINOSUS</strong></p><p>Intranasal ketamine is an effective, safe treatment for status migrainosus. Adverse effects may include nasal irritation or nausea. Intranasal administration is not associated with the panic symptoms, euphoria or blood pressure changes that can be seen with IV dosing.</p><p><strong>When to consider intranasal ketamine for migraine in the Emergency Department:</strong></p><p>1. Patient has failed/cannot tolerate DHE.</p><p>2. Patient has taken triptan within 24 hours.</p><p>3. Patient without IV access</p><p>4. Good response to ketamine for migraine in the past.</p><p>5. Multiple ED visits within 48-96H and migraine keeps returning after cocktail/DHE.</p><p><strong>Intranasal ketamine dosing for migraine: </strong>0.1-0.2 mg/kg/dose (maximum 20 mg/dose). May repeat every 15 minutes as needed for ongoing pain to a total of 5 doses (total max 100 mg).</p><p><strong>Inpatient ketamine use: </strong> IV ketamine treatment in the inpatient setting is managed by the Acute Pain. APS should be involved in any admission decisions involving ketamine.</p><h1 id=\"migraine-pathophysiology\">Migraine Pathophysiology</h1><p>I</p>",
  "imageCount": 4,
  "chunkCount": 21
}